Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioSpace

17:12 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "BioSpace" found in our extensive news archives from over 250 global news sources.

More Information about BioSpace on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioSpace for you to read. Along with our medical data and news we also list BioSpace Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioSpace Companies for you to search.

Showing News Articles 1–25 of 1,800+ from BioSpace

Monday 10th December 2018

AbbVie Continues Charitable Giving, Donates $50 Million to St. Jude

Christmas came a little early for St. Jude Children’s Research Hospital in the form of a $50 million contribution from pharma giant AbbVie – the largest single contribution made to the famed hospital.

Big Drug Launches Have Taught Drug Companies Some Important Lessons

With the closure of another year just weeks ahead, this time of year is one that many people use to take a look behind and see what lessons were learned over the past 12 months. For the world of biopharma, it’s also important to see what lessons have been learned.

NIH to Spend $20 Million on a Search for the Development of Alternatives to Fetal Tissue

As the Trump administration has continued to show its lack of financial support of scientific research using fetal tissue, the National Institutes of Health is setting aside $20 million to fund research that could develop alternatives to the use of embryonic tissue.

Artificial Intelligence Is the Next Big Player in Genomics

According to consultant firm Frost & Sullivan, artificial intelligence (AI) systems will be the next big players in both global healthcare and individual gene editing. By 2021, the firm predicts that AI will be responsible for 6.7 billion dollars in revenue.

Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials

White Americans make up the vast majority of clinical trial participants, despite evidence that some cancers affect minority populations in greater numbers.

Sprayable Gel May Help Fight off Cancer Recurrence After Surgery

A group of researchers from UCLA have developed a spray gel that contains immune-stimulating drugs. The gel was effective about 50 percent of the time in stimulating laboratory animals’ immune systems to stop cancer from recurring and inhibiting its metastases.

WuXi Biologics and Oxford BioTherapeutics Expand Partnership with 5 More Antibody Compounds

WuXi Biologics, a Shanghai, China-based contract research organization focused on biologics, announced it was expanding its existing collaboration and licensing deals with UK-based Oxford BioTherapeutics (OBT).

Career Advice from a Scientist and Serial Entrepreneur

Dinko Valerio offers wisdom garnered from a long career as a scientist, investor and entrepreneur.

AbbVie Continues Charitable Giving, Donates $100 Million to St. Jude

Christmas came a little early for St. Jude Children’s Research Hospital in the form of a $50 million contribution from pharma giant AbbVie – the largest single contribution made to the famed hospital.

Sunday 9th December 2018

Gilead Taps Roche Veteran Daniel O’Day as New CEO

Gilead Sciences officially announced that long-time Roche veteran, Daniel O’Day, will assume the helm of the company as chairman and chief executive officer beginning March 1. O'Day takes over for John Milligan, who announced his plans to retire by the end of the year in July.

WuXi AppTec to Expand Facilities and Hire in San Diego

At its San Diego site, the company plans to establish a center of excellence in screening, discovery biology, pharmacology, and small molecule process R&D, which will also include Phase I GMP manufacturing.

The Genome of Giant Tortoise "Lonesome George" Provides Clues to Longevity and Disease Resistance

Researchers published an article in the journal Nature Ecology & Evolution today that described preliminary findings of gene variants in George associated with a strong immune system, efficient DNA repair and cancer resistance.

At Least 16 Generic Drug Companies and 300 Drugs Target of Price-Fixing Investigation

It apparently began with a 2016 federal lawsuit. At that time, 20 state attorneys general filed a federal lawsuit alleging that six generic drug makers artificially inflated and manipulated prices for an antibiotic and an oral diabetes drug. The goal was to reduce competition.

BioSpace Movers and Shakers for Dec. 10

Biotech and pharma companies strengthen their leadership teams with these appointments. Who made power moves in the industry this past week?

New Report Shows More Failures to Disclose Potential Conflicts of Interest in Journal Articles

More journal articles are revealed to lack full disclosure of the authors' ties to the pharmaceutical industry.

PhRMA Highlights Impact of Cell and Gene Therapies in New Report

This morning the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that shows there are nearly 300 novel cell and gene therapies currently in development throughout the industry. The therapies are being studied as treatments for a variety of diseases and conditions.

Axovant Abandons Another Dementia Drug After Failed Trial

There is very little doubt that developing drugs for neuroscience disorders in general and dementias in particular is a high-risk business. Axovant Sciences, unfortunately, seems to be finding that out the hard way.

The Top 10 Non-Traditional Careers for Life Science Professionals

Many recent college graduates with science degrees wonder, “What other careers are available outside of a laboratory or research environment?” Concurrently, a large amount of mid-career and late-career professionals consider pursuing non-traditional science roles.

What’s Going on With the Biosimilar Market?

Although a moderate presence in Europe, with about 25 biosimilars approved and on the market, they haven’t gained traction in the U.S. Even though at least 11 have been approved in the U.S., only about three are available, largely because of business tactics branded drug companies are using to sl...

7 Cool Examples of How Researchers Turn to Nature for Inspiration

Biomimicry, looking at how things are done in nature and applying that to solve problems, is utilized by many researchers. BioSpace looks at some examples of how scientists are performing cutting-edge research using biomimicry.

Friday 7th December 2018

Top 12 Life Sciences Companies Hiring Now for Candidates Like You

Winter and the Holidays are right around the corner, but don't stop your job search! Check out the top companies who are looking for candidates like you right now!

Help Us to Better Serve You!

At BioSpace, we're continually searching for better ways to serve our community, but we need your help to do so.

Thursday 6th December 2018

Moderna Therapeutics Sets Record for Biggest Biotech IPO

The long-awaited and massively hyped initial public offering of Moderna Therapeutics hit the market yesterday. The company sold approximately 26.3 million shares priced at $23 a share. This exceeded the revised goal of $600 million by about $4.3 million.

FDA Doubles Down on Use of Real-World Data for Regulatory Decisions

The U.S. Food and Drug Administration (FDA) released a new 2019 strategic Framework for how it plans to advance the use of so-called real-world data (RWD) to improve regulatory decisions. The agency has indicated that this is a strategic priority.

Mallinckrodt Plans to Spin off Its Generics Business

Shares of Mallinckrodt PLC are down nearly 2 percent in morning trading after the company announced it will spin off a new company that includes its specialty generics business to shareholders by the second half of 2019.


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks